Your browser doesn't support javascript.
loading
Primary cardiac lymphoma presenting with cardiac tamponade and complete heart block: case report.
Kelleher, Ruth; Bird, Brian Healey; Hayes, Tríona; O'Sullivan, Crochan J.
Afiliação
  • Kelleher R; Department of Radiation Oncology, Cork University Hospital, Wilton Road, T12 DC4A Cork, Ireland.
  • Bird BH; Department of Oncology, Bon Secours Hospital Cork, College Road, Cork, Ireland.
  • Hayes T; Department of Medicine, University College Cork, College Road, Cork, Ireland.
  • O'Sullivan CJ; Department of Pathology, Bon Secours Hospital Cork, College Road, Cork, Ireland.
Eur Heart J Case Rep ; 8(1): ytad635, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38223510
ABSTRACT

Background:

Primary cardiac lymphoma (PCL) is rare and its presentation can be variable. Thorough workup of suspected PCL or other cardiac tumours typically incorporates a range of imaging techniques and laboratory investigations but ultimately diagnosis is confirmed by histological analysis of myocardial tissue. Case

Summary:

An 80-year-old Caucasian female presented with complete heart block and symptomatic cardiac tamponade. A pericardiocentesis was performed and a dual-chamber permanent pacemaker was implanted for the management of her complete heart block. Subsequently, a right atrial mass was discovered on imaging and the patient underwent endomyocardial biopsy of the mass. Histological analysis of the sample confirmed a primary cardiac lymphoma. The patient opted to forgo treatment with chemotherapy and died from her disease 1 month later.

Discussion:

Cardiac arrhythmias can occur in PCL due to infiltration of conduction pathways. Characterization of cardiac masses on various imaging modalities and laboratory tests guides diagnosis. Tissue diagnosis is required to confirm PCL. The location of a cardiac mass may present technical challenges when undertaking a biopsy, so the best approach to tissue sampling should be considered on an individual basis. Without treatment survival is less than one month but with modern chemoimmunotherapy five-year survival may exceed 50%.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article